76 related articles for article (PubMed ID: 21438025)
1. Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells.
Koumakpayi IH; Le Page C; Delvoye N; Saad F; Mes-Masson AM
Mol Carcinog; 2011 Nov; 50(11):901-12. PubMed ID: 21438025
[TBL] [Abstract][Full Text] [Related]
2. Expression and nuclear localization of ErbB3 in prostate cancer.
Koumakpayi IH; Diallo JS; Le Page C; Lessard L; Gleave M; Bégin LR; Mes-Masson AM; Saad F
Clin Cancer Res; 2006 May; 12(9):2730-7. PubMed ID: 16675564
[TBL] [Abstract][Full Text] [Related]
3. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
Wang S; Huang X; Lee CK; Liu B
Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
[TBL] [Abstract][Full Text] [Related]
5. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
6. Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer.
Koumakpayi IH; Diallo JS; Le Page C; Lessard L; Filali-Mouhim A; Bégin LR; Mes-Masson AM; Saad F
BJU Int; 2007 Aug; 100(2):303-9. PubMed ID: 17532856
[TBL] [Abstract][Full Text] [Related]
7. Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines.
Bonaccorsi L; Nosi D; Muratori M; Formigli L; Forti G; Baldi E
J Mol Endocrinol; 2007 Feb; 38(1-2):51-66. PubMed ID: 17242169
[TBL] [Abstract][Full Text] [Related]
8. The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway.
Lau AW; Chou MM
J Cell Sci; 2008 Dec; 121(Pt 24):4008-17. PubMed ID: 19033387
[TBL] [Abstract][Full Text] [Related]
9. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
Ishizawar RC; Miyake T; Parsons SJ
Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
11. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
[TBL] [Abstract][Full Text] [Related]
12. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
14. Activated ErbB3 Translocates to the Nucleus via Clathrin-independent Endocytosis, Which Is Associated with Proliferating Cells.
Reif R; Adawy A; Vartak N; Schröder J; Günther G; Ghallab A; Schmidt M; Schormann W; Hengstler JG
J Biol Chem; 2016 Feb; 291(8):3837-47. PubMed ID: 26719328
[TBL] [Abstract][Full Text] [Related]
15. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.
Chen X; Yeung TK; Wang Z
Biochem Biophys Res Commun; 2000 Nov; 277(3):757-63. PubMed ID: 11062025
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow.
Vakar-Lopez F; Cheng CJ; Kim J; Shi GG; Troncoso P; Tu SM; Yu-Lee LY; Lin SH
J Pathol; 2004 Jun; 203(2):688-95. PubMed ID: 15141384
[TBL] [Abstract][Full Text] [Related]
18. The Listeria protein internalin B mimics hepatocyte growth factor-induced receptor trafficking.
Li N; Xiang GS; Dokainish H; Ireton K; Elferink LA
Traffic; 2005 Jun; 6(6):459-73. PubMed ID: 15882443
[TBL] [Abstract][Full Text] [Related]
19. ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin.
Poupart ME; Fessart D; Cotton M; Laporte SA; Claing A
Cell Signal; 2007 Nov; 19(11):2370-8. PubMed ID: 17719203
[TBL] [Abstract][Full Text] [Related]
20. Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells.
Cheng CJ; Ye XC; Vakar-Lopez F; Kim J; Tu SM; Chen DT; Navone NM; Yu-Lee LY; Lin SH; Hu MC
Mol Cancer Res; 2007 Jul; 5(7):675-84. PubMed ID: 17634423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
